Science and Enterprise

Tag: biotechnology

  • Report: Pharma Research Productivity Undercounted

    In a new analysis, pharmaceutical market research company EvaluatePharma in London, U.K. says current methods of measuring productivity of the industry miss a big part of the industry’s output and thus give a misleading picture. The report suggests the pharma industry is in better shape than most observers indicate. EvaluatePharma says most industry watchers count…

  • Finance Friday: 11 March 2011

    Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy, Fierce Biotech, and Venture Capital Reporter. Biomedical/Life Sciences Kite Pharma, a start up biotech in Los Angeles, California developing new cancer vaccine therapies, took in $15 million in Series A venture funding, from TPG Capital and other investors.…

  • Evotec to Partner with HHMI, Harvard on Diabetes Drugs

    Evotec AG, a biotechnology company in Hamburg, Germany announced today a research collaboration with Harvard University in Cambridge, Massachusetts and Howard Hughes Medical Institute (HHMI), in Chevy Chase, Maryland to discover and develop new diabetes treatments. The partnership aims to identify and develop physiological mechanisms and targets that regulate beta cell replication. Beta cells are…

  • New Balloon Catheter Reduces Cardiac Surgery Invasiveness

    A team of materials scientists, engineers, and physicians has successfully integrated stretchable electronics technology with standard balloon catheters now used inside the heart. The researchers from several universities and a company commercializing the technology, published their findings in the current online issue of the journal Nature Materials (paid subscription required). Catheters are long, flexible tubes…

  • Finance Friday: 4 March 2011

    Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy and Venture Capital Reporter. Biomedical/Life Sciences Retina Implant AG in Reutlingen, Germany, a medical device company developing sub-retinal implants to help visually impaired people improve their sight, secured $18 million in its second round of equity funding from…

  • Lycera Corp., Merck to Partner on Autoimmune Drugs

    Lycera Corporation, a biopharmaceutical company in Plymouth, Michigan, says it has a collaboration agreement with the global drug maker company Merck to develop drug candidates that treat major autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease, and multiple sclerosis. Under the agreement, Lycera can receive up to $307 million, as well as later…

  • Dow to Release Control System for Herbicide-Adaptive Weeds

    Dow AgroSciences in Indianapolis, Indiana unveiled a new weed control system designed to counter the ability of weeds to adapt to common herbicides such as 2,4-D and glyphosates. The company says the new Enlist system builds on its previous work in chemistry and biotechnology. The product was designed to help farmers reduce weeds that have…

  • Contracts Awarded for New Flu Vaccine Technologies

    The U.S. Department of Health and Human Services (HHS) awarded contracts to two companies to help make flu vaccines available quickly for seasonal outbreaks and pandemics. The contracts total $215 million from HHS’s Biomedical Advanced Research and Development Authority. HHS awarded one contract to Novavax Inc., of Rockville, Maryland, for $97 million over the first…

  • Biotech Licenses Technology for Colorectal Cancer Blood Test

    Epigenomics AG in Berlin, Germany says it has an agreement for QIAGEN NV in the Netherlands to further develop Epigenomics’s research into a blood test for colorectal cancer. QIAGEN also has an option under the agreement to take the blood test to market. The technology is based on Epigenomics’s research into genomics and DNA indicators…

  • Finance Friday: 25 February 2011

    Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy. Biomedical/Life Sciences CardioFocus in Marlborough, Massachusetts. Attrial fibrilliation devices. $13.6 million in equity financing. CalciMedica in San Diego, California. Biotech with experimental psoriasis candidate. $6 million in venture financing. Acetylon Pharmaceuticals, in Boston, Massacusetts. Drugs to treat cancer…